
eDetect represents our main, most modern, and most advanced PCR diagnostic line. The first eDetect kits are to be launched in 2027/28. They are the result of our own new R&D department, meaning these products have been developed completely by Ecoli Dx. We are proud to use our own chemistry for the production of eDetect kits. Also, we are proud to use raw materials with EU origin only (the main components are from Germany and the Czech Republic). As the production takes place locally in our facility in the Czech Republic, we have absolute control over quality, which means improved warranty and support for you, as well as short lead times. All products are to be CE marked under Regulation (EU) 2017/746 (IVD-R). The upcoming portfolio will include two STI multiplex kits (CT-NG and MG-MH-US), two quantitative herpetic-viruses multiplex kits (CMV-EBV-HHV6 and HSV1-HSV2-VZV), quantitative kits for HBV and HCV, and detection kits for Toxoplasma gondii, Rubella virus, and Parvovirus B19.



